Ainos, Inc.

Ainos, Inc. reported a net loss of $(2.46) million for the three months ended March 31, 2026, an improvement from a net loss of $(3.29) million in the prior year. However, revenue significantly decreased to $161 from $106,207 in Q1 2025. The company bolstered its liquidity by raising $601,600 in net proceeds from its At-the-Market (ATM) offering and securing a $2.81 million loan from a related party, increasing its cash and cash equivalents to $2.84 million. Despite these financing activities, the company continues to face substantial doubt about its ability to continue as a going concern due to accumulated deficits and ongoing losses.

Ainos, Inc. reported a net loss of $2.46 million for the first quarter ended March 31, 2026, an improvement from a $3.29 million net loss in the prior year's quarter. Revenue for the quarter was $161, a substantial decrease from $106,207 year-over-year, reflecting a transition towards industrial and infrastructure-focused AI Nose deployments. Operating expenses decreased by approximately 30% to $2.28 million, and the company strengthened its balance sheet with a NT$90 million (approximately US$2.8 million) financing arrangement. Ainos highlighted continued progress in commercializing its AI Nose technology across semiconductor and healthcare infrastructure markets, with ongoing deployment and pilot activities.